2020
DOI: 10.1016/s2213-2600(20)30071-0
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
332
2
29

Year Published

2020
2020
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 341 publications
(371 citation statements)
references
References 3 publications
8
332
2
29
Order By: Relevance
“…Arbidol and arbidol mesylate were shown to have a potent inhibitory effect in reducing the reproduction of SARS-CoV in vitro [80] . Low-level evidence including a retrospective cohort study, case reports and case series revealed that arbidol alone or combined with antiviral drugs produced certain benefits in the treatment of COVID-19 pneumonia [81][82][83] . Currently, many randomised clinical controlled trials are being carried out studying the efficacy of Arbidol on COVID-19 pneumonia in China.…”
Section: Arbidol (Umifenovir)mentioning
confidence: 99%
“…Arbidol and arbidol mesylate were shown to have a potent inhibitory effect in reducing the reproduction of SARS-CoV in vitro [80] . Low-level evidence including a retrospective cohort study, case reports and case series revealed that arbidol alone or combined with antiviral drugs produced certain benefits in the treatment of COVID-19 pneumonia [81][82][83] . Currently, many randomised clinical controlled trials are being carried out studying the efficacy of Arbidol on COVID-19 pneumonia in China.…”
Section: Arbidol (Umifenovir)mentioning
confidence: 99%
“…4,5 Mortality rates are estimated at 3.6%. 6 An elevated C-reactive protein (CRP) and lymphopenia (<1,100 m/L) are characteristic 7 Radiology departments should be prepared for an increase in the number of cases of COVID-19 and new diagnoses or risk stratification may be imaging based. As such, it is important for radiologists to be familiar with the potential spectrum of imaging findings, as well as set out protocols to limit contamination and spread.…”
Section: Clinical Presentation Of Covid-19mentioning
confidence: 99%
“…Fever Clinics, mostly affiliated to the Division of Infectious Diseases in general hospitals, had been established after SARS outbreak in 2003, and since then served as the first line to monitor and manage acute febrile respiratory infections, mostly seasonal influenza in recent years. For 2019 novel coronavirus disease (COVID- 19), this time, patients with body temperatures≥37.2 o C were asked to firstly visit Fever Clinics, where a triage strategy was implemented 9 , and probable or possible cases were identified by experts or expert panels, and samples were sent for quick viral detection. On Jan. 21, 2020, the first case of COVID-19 was identified in our Fever Clinic, and up to Feb. 15, 21 cases were diagnosed, with 19 cases confirmed by positive 2019-nCoV results, among 88 patients with pneumonia sent for viral detection.…”
Section: Introductionmentioning
confidence: 99%